Intrinsic Value of S&P & Nasdaq Contact Us

InnovAge Holding Corp. INNV NASDAQ

NASDAQ Global Select • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
29/100
1/7 Pass
SharesGrow Intrinsic Value
$148.66
+1719.6%
Analyst Price Target
$6.80
-16.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

InnovAge Holding Corp. (INNV) has a negative trailing P/E of -273.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 32.4 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -0.37%, forward earnings yield 3.09%. PEG 0.74 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (20/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -273.2); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -0.37%); analyst consensus target implies downside from the current price ($6.80, 16.8%).
  • Forward P/E 32.4 — analysts expect a return to profitability with estimated EPS of $0.25 for FY2026.
  • PEG Ratio 0.74 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -0.37% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 3.09% as earnings recover.
  • Analyst consensus target $6.80 (-16.8% downside) — analysts see meaningful downside risk at the current price level.

Overall SharesGrow Score: 29/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
29/100
SG Score
View full scorecard →
VALUE
20/100
Price-to-Earnings & upside
Proven by this page
FUTURE
16/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
~
GROWTH
40/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — INNV

Valuation Multiples
P/E (TTM)-273.2
Forward P/E32.4
PEG Ratio0.74
Forward PEG0.74
P/B Ratio4.38
P/S Ratio1.23
EV/EBITDA44.3
Per Share Data
EPS (TTM)$-0.03
Forward EPS (Est.)$0.25
Book Value / Share$2.13
Revenue / Share$6.72
FCF / Share$0.34
Yields & Fair Value
Earnings Yield-0.37%
Forward Earnings Yield3.09%
Dividend Yield0.00%
SharesGrow IV$148.66 (+1719.6%)
Analyst Target$6.80 (-16.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 164.6 0.00 43.44 6.92 2.06%
2020 122.7 3.68 31.91 5.68 -
2021 -65.7 0.25 8.63 4.53 0.33%
2022 -91.0 1.07 1.79 0.85 -
2023 -25.0 -0.05 3.78 1.48 -
2024 -32.1 0.69 2.54 0.90 -
2025 -16.5 -0.44 2.13 0.59 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $0.15 $465.63M $19.58M 4.2%
2020 $0.20 $567.19M $26.28M 4.6%
2021 $-0.33 $637.8M $-44.74M -7%
2022 $-0.06 $698.64M $-7.96M -1.1%
2023 $-0.30 $688.09M $-40.67M -5.9%
2024 $-0.16 $763.86M $-21.34M -2.8%
2025 $-0.22 $853.7M $-30.31M -3.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.25 $0.21 – $0.30 $944.53M $938.08M – $950.48M 2
2027 $0.34 $0.24 – $0.43 $1.03B $1.02B – $1.04B 2
2028 $0.52 $0.52 – $0.53 $1.11B $1.11B – $1.11B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message